Trial Profile
A Real World Study Investigating the Effects of Multiple NS5A RASs in a Cohort of NS5A Inhibitor‐Naive Patients with Chronic Hepatitis C Virus Genotype 1b Infection Treated with Sofosbuvir and Ledipasvir (SOF/LDV) Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 02 Nov 2018 New trial record